A Dual‐Nanozyme‐Catalyzed Cascade Reactor for Enhanced Photodynamic Oncotherapy against Tumor Hypoxia
Hypoxia
DOI:
10.1002/adhm.202101049
Publication Date:
2021-09-08T10:35:35Z
AUTHORS (8)
ABSTRACT
Abstract Tumor hypoxia is a typical characteristic of tumor microenvironment (TME), which seriously compromises the therapeutic effect photodynamic therapy (PDT). The development nanozymes with oxygen‐generation ability promising strategy to overcome oxygen‐dependent PDT but remained great challenge. Herein, dual‐nanozymes based cascade reactor HAMF proposed alleviate for enhanced PDT. hollow mesoporous silica nanoparticles (HMSNs) are constructed as an excellent nanocarrier load ultra‐small gold (Au NPs) and manganese dioxide (MnO 2 ) shell via in situ reduction method, further coordination efficient photosensitizer 4‐DCF‐MPYM (4‐FM), thermally activated delayed fluorescence (TADF) fluorescein derivative. With response TME, MnO can catalyze endogenous H O into subsequently accelerating glucose oxidation by Au NPs produce additional , reversely used substrate ‐catalyzed reaction, thereby constantly producing singlet oxygen ( 1 upon light irradiation. This work on dual‐nanozyme relieve effective suppression, may enrich application multi‐nanozymes biomedicine.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (45)
CITATIONS (61)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....